Journal of Applied Physiology Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 90: 2257-2268, 2001;
8750-7587/01 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, B. J.
Right arrow Articles by Pierson, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, B. J.
Right arrow Articles by Pierson, R. N., III
Vol. 90, Issue 6, 2257-2268, June 2001

Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection

Brendan J. Collins1, Matthew G. Blum1, Richard E. Parker2, Andrew C. Chang1, Kelly S. A. Blair1, George L. Zorn III1, Brian W. Christman2, and Richard N. Pierson III1

Departments of 1 Cardiothoracic Surgery and 2 Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical School and Nashville Veterans Affairs Medical Center, Nashville, Tennessee 37232

The role of thromboxane (Tx) in hyperacute rejection of pig lung by human blood was studied in an ex vivo model, wherein lungs from juvenile piglets were perfused with fresh heparinized human blood. In this model, hyperacute lung rejection was characterized by an abrupt rise in pulmonary vascular resistance (PVR; >1 cmH2O · ml-1 · min) and prolific Tx elaboration (>15 ng/ml) within 5 min and loss of function within 10 min. Although papaverine significantly blunted the rise in PVR (<0.2 cmH2O · ml-1 · min), Tx production was not inhibited (>20 ng/ml), and florid tracheal edema was usually evident within 20 min. In contrast, both inhibition of Tx synthesis (Tx < 3 ng/ml) with OKY-046 and blockade of the Tx receptor with SQ-30741 (Tx > 20 ng/ml) were not only associated with significantly lower peak PVRs (<0.2 cmH2O · ml-1 · min) but also with attenuated increase in lung wet-to-dry ratio and airway edema. In concert, elaboration of histamine and tumor necrosis factor was blunted, and median survival increased >10-fold to 2 h (SQ-30741) and >4 h (OKY-046). Depletion of the pig lung macrophages with dichloromethyl bisphosphonate in liposomes, but not Pall filtration of the human blood or liposomes alone, significantly inhibited Tx elaboration (<0.2 vs. >8 ng/ml for Pall filtration or liposomes) and blunted PVR elevation (<0.3 cmH2O · ml-1 · min) during initial perfusion. C3a and histamine elaboration were inhibited, and median survival was significantly prolonged (>4 h). These findings implicate Tx in the inflammation associated with hyperacute lung rejection and demonstrate that pulmonary intravascular macrophages are critical to its elaboration.

xenotransplantation; microvascular permeability; macrophage; platelet; neutrophil; eicosanoid


This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. P. O'Dea, M. R. Wilson, J. O. Dokpesi, K. Wakabayashi, L. Tatton, N. van Rooijen, and M. Takata
Mobilization and Margination of Bone Marrow Gr-1high Monocytes during Subclinical Endotoxemia Predisposes the Lungs toward Acute Injury
J. Immunol., January 15, 2009; 182(2): 1155 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. J. Kang, G. Lee, J. Y. Kim, S. H. Lee, H. C. Wi, P. G. Hwang, D. H. Chung, and Y. T. Kim
Pre-treatment of donor with 1-deamino-8-D-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 149 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Singh, J. W. Pearce, L. N. Gamage, K. Janardhan, and S. Caldwell
Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L363 - L372.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. R. Karamsetty and J. R. Klinger
NO: More Than Just a Vasodilator in Lung Transplantation
Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 1 - 5.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Pfeiffer, G. L. Zorn III, S. Kelishadi, R. Oriol, P. Wolf, R. N. Pierson III, and A. M. Azimzadeh
Role of anti-Gal{alpha}1,3Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood
Ann. Thorac. Surg., November 1, 2001; 72(5): 1681 - 1690.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online